Meet our members

Dr. Jennifer Arnold

Consultant Ophthalmologist, Marsden Eye Specialists, Australia

Dr. Jennifer Arnold is an ophthalmologist and medical retinal subspecialist working in Sydney, Australia, where she is a partner at Marsden Eye Specialists. As well as performing clinical duties, Dr. Arnold is involved in clinical research, coordinating a research department of ophthalmologists, orthoptists and registered nurses that conduct international and local clinical trials into retinal diseases.

Dr. Arnold contributes to numerous publications; is involved in teaching, advisory boards and audit groups; and in 2012 became Chair of the Grants Review and Awards Committee for the Global Ophthalmology Awards Program from Bayer. She is a member of the Macula Society.

Dr. Arnold’s main research focus is the development of new treatments for AMD, DME, and RVO. Indeed, she was involved in the revolutionary work carried out in recent years to improve the diagnosis and management of AMD.

Prof. Tariq Aslam

Consultant Ophthalmologist, Manchester Royal Eye Hospital, UK

Tariq Aslam began his medical training at the University of Oxford and completed his fellowship at Moorfields Eye Hospital. He is a Consultant Ophthalmologist at Manchester Royal Eye Hospital, specializing in medical retina, and is a Reader at the University of Manchester. He has a research doctorate from the University of Oxford involving clinical trials and another PhD from Heriot-Watt University on technology applications in ophthalmology, which utilized his skills in computer programming and led to the award of a professorship.

His research explores many clinical interests in retina, including psychological aspects and the potential for computerized and technological enhancement of patient care including novel device development. He has around 100 peer-reviewed publications, predominantly as lead author, a number of patents, and is an investigator on multiple commercial and investigator-led studies. His research has led to a spin-out medical technology company with awards for social impact, which is his ultimate research goal.

Prof. Yuri Astakhov

Head of Ophthalmology and Consultant Ophthalmologist, St. Petersburg State Medical University, Russia

Professor Yuri Astakhov, MD, PhD, completed his medical degree, residency and postgraduate education at the First Pavlov State Medical University of St. Petersburg, Russia. At this university, he held the positions of Chair and Director of the Ophthalmology Clinic for more than 20 years, and is now professor. He is Doctor Honoris Causa of the university and Vice President of the All-Russian Association of Ophthalmologists. He is also director of the City Ophthalmology Center.

Professor Astakhov has extensive clinical research experience in a range of ophthalmology subspecialties, including glaucoma, retinal diseases, and vascular pathology of the eye. He has been involved as principal investigator in more than 20 clinical trials since 1997. He is author and co-author of several monographs and more than 500 scientific publications, and is an Editor-in-Chief of the ophthalmologic magazine ‘Oftalmologiceskie Vedomosti’.

Prof. Francesco Bandello

Professor, Scientific University Institute San Raffaele, Italy

Francesco Bandello is a Professor at the Scientific University Institute San Raffaele in Milan, Italy. He is former President of EURETINA, Vice President of Academia Ophthalmologica Europea, and a board member of EuroLam Retina.

Professor Bandello is Associate Editor of the European Journal of Ophthalmology and a former board member of the Club Jules Gonin and the Macula Society. He is also a member of the Academia Ophthalmologica Internationalis and Accademia Nazionale di Medicina, and serves as a peer-reviewer for grant applications for the National Eye Institute.

Professor Bandello has authored or co-authored more than 154 articles, which are mainly related to retinal diseases. His scientific interests include the study of new therapeutic agents for the inhibition of angiogenesis and/or vasculogenesis in cases of proliferative diabetic retinopathy and AMD; biomarkers in AMD; the correlation between systemic and ophthalmic vascular diseases; and medical robotics and bioengineering.

Dr. Jane Barratt

Secretary General, International Federation on Ageing, USA

Jane Barratt is the Secretary General of the International Federation on Ageing (IFA), which comprises government, industry, academic, and non-governmental members in over 70 countries, representing some 75 million older people. The IFA is a global point of connection for experts and it provides expertise that helps to shape and influence age-related policy globally.

Jane has direct responsibility for the IFA’s global operational performance, quality and strategic implementation, and business development. This includes leadership at the United Nations Economic and Social Council in New York, Geneva, and Vienna, and formal relations with the Department of Ageing and Life Course at the World Health Organization.

Through this leadership, the IFA has led the groundbreaking global study on diabetic retinopathy which goes towards helping to build capacity and capability at a national level to influence and shape policy that improves patient outcomes.

Jane has many national and international roles, including Chair, Standing Selection Committee Chair for the Networks of Centres of Excellence of Canada, and she is a former member of the Global Agenda Council on Ageing for the World Economic Forum.

Dr. Ziad Bashshur

Professor of Ophthalmology, American University of Beirut, Lebanon

Ziad Bashshur is Professor of Ophthalmology at the American University of Beirut (AUB), and is also a full-time attending retina specialist at the AUB medical center with research and teaching responsibilities. His main clinical focus is vitreoretinal diseases and surgery, and his major research interest is in retinal vascular disease, in particular wet age-related macular degeneration.

In addition to obtaining his medical degree and completing his ophthalmology residency at the AUB, Dr. Bashshur also completed an internship in internal medicine at Georgetown, Virginia medical center and a vitreoretinal fellowship at the University of Virginia, USA.

Dr. Bashshur sits on several advisory boards within the medical industry and has spoken at a number of professional meetings worldwide. He has authored over 40 publications in peer-reviewed journals, and is a reviewer for several ophthalmology journals including Retina, American Journal of Ophthalmology, and JAMA Ophthalmology.

Prof. Francine Behar-Cohen

Medical Director, Jules Gonin Eye Hospital, Switzerland

Professor Francine Behar-Cohen has been Medical Director of the Jules Gonin Eye Hospital in Lausanne, Switzerland, since 2013, and is a Full Professor at the University of Lausanne and the Paris Descartes University. She is Director of the ‘Physiopathology of ocular diseases: Therapeutic innovations’ team at the French National Institute of Health and Medical Research in the Cordeliers Research Center in Paris. Professor Behar-Cohen is also the founder of start-up companies Optis France (now Eyegate Pharma) and Eyevensys S.A.S. (for which she serves as scientific advisor). In addition to her medical degree, Professor Behar-Cohen has obtained a diploma of advanced studies in cell biology, a diploma of specialized studies in ophthalmology, and a PhD in biology at the Paris Descartes University.

Professor Behar-Cohen has received awards for her research, including the Research Prize of the French Society of Ophthalmology, and is a member of numerous societies and scientific commissions. She is a member of the editorial board of Molecular Vision, the Journal of Ocular Pharmacology and Therapeutics, Translational Vision Science and Technology, and Progress in Retinal and Eye Research. She has published more than 190 articles and a dozen books or book chapters.

Professor Behar-Cohen’s research interests include the development of innovative treatments and methods of administration for drugs in the eye (particularly for diseases of the retina), and mechanisms of action of steroids and anti-VEGF agents in the retina. She has introduced the use of mineralocorticoid receptor antagonists for the treatment of central serous chorioretinopathy.

Dr. Alan Berger

Ophthalmologist-in-Chief (St. Michael’s Hospital) and Vice Chair of the Department of Ophthalmology and Vision Sciences (University of Toronto), Canada

Dr. Alan Berger is the former Ophthalmologist-in-Chief at St. Michael’s Hospital in Toronto, Ontario, Canada (2002–2014) and is the current Vice Chair of the Department of Ophthalmology and Vision Sciences at the University of Toronto. He received his BSc with honors in human genetics and his medical degree (MD, CM) from McGill University in Montreal, Quebec, Canada. After completing an internship in internal medicine, he did 3 years of ophthalmology residency training at the University of Toronto, followed by an 18-month subspecialty fellowship in diseases and surgery of the retina and vitreous at Washington University in St. Louis in Missouri, USA. In 1989, he joined the Department of Ophthalmology and Vision Sciences at the University of Toronto, working at Sunnybrook Health Sciences Centre as the Director of their Vitreoretinal Surgical Unit.

Dr. Berger has served on numerous hospital, university, ministry of health and community committees and boards, and is currently Vice President of the Toronto Ophthalmological Society. He is one of the co-founders of the Toronto Retina Institute, and was Chair of the Retina Canada meeting in 2004 and Chair of the Canadian Surgical Retina meetings in 2005 and 2006. He has authored numerous peer-reviewed scientific journal articles, written 6 book chapters, and has spoken at numerous national and international meetings. He has been and continues to be active as principal investigator and co-investigator for vitreoretinal clinical trials in diabetic retinopathy, AMD, ocular trauma, macular holes, and retinal detachment.

Dr. Susanne Binder

Professor of Special Ophthalmology, Sigmund Freud University, Austria

Dr. Susanne Binder, MD was born in Vienna and completed her medical training at the University of Vienna. She received subspecialized training in vitreoretinal surgery and research in 1979/80 at the Johns Hopkins University in Maryland, USA and the Duke Eye Center in Durham, USA. She has been a Professor of Ophthalmology since 1988. In 2012 she was appointed Adjunct Professor of Clinical Ophthalmology at Weill Cornell Medical College in New York, and in 2017 she was appointed Professor of Special Ophthalmology at Sigmund Freud University in Vienna.

Dr. Binder’s subspecialty is vitreoretinal diseases and microsurgery, and she has conducted research in age-related macular degeneration, retinal regeneration treatments such as retinal cell transplantation and retinal implants, and imaging. In optical coherence tomography (OCT) she has developed a new OCT-integrated microscope in collaboration with Carl Zeiss Meditec in Oberkochen, Germany.

Dr. Binder was vice-chairman of the University Eye Clinic in Vienna from 1990 before she received chairmanship (Primariat) of the Department of Ophthalmology at the Rudolf Foundation Clinic, a teaching hospital in the medical university of Vienna, in 1995. She remained chairman until 2015 and led the Eye Center Project of the Wiener Krankenanstaltenverbund (KAV) in Vienna until 2017. She also chaired the Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery between 1997 and 2015. Today Dr. Binder continues her scientific work at the Karl Landsteiner Institute for Imaging and Retinal Research at the Rudolf Foundation in Vienna and Sigmund Freud University.

Dr. Binder has published more than 380 original peer-reviewed articles in both English and German. She was Editor-in-Chief of the Austrian ophthalmic journal, Spektrum der Augenheilkunde, has been an editor of four books, and has written a number of book articles. Dr. Binder is also a member of many ophthalmic societies including the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology (ARVO), the Retina Society, the Macula Society, the Club Jules Gonin, the Association of Retina Specialists, and the Austrian and Viennese Ophthalmic Societies. She was President of the Austrian Ophthalmic Society between 2004 and 2009, secretary of the Austrian Ophthalmic Society between 2009 and 2011, and was a member of the Medical Counsel for the Minister of Health in Austria and the Mayor of Vienna.

Dr. Binder has trained many young ophthalmologists and organized surgical training weeks (wet labs) for hands-on training, as well as several international conferences in Vienna. She participated in the American Austrian Foundation project, the European Society of Ophthalmology, and is a regularly invited lecturer and speaker at national and international meetings.

Prof. Maria Budzinskaya

Head of Department of Clinical Trials in Ophthalmology and deputy director of research work for the Federal State Budget Scientific Research Institute, the Scientific Research Institute of Eye Diseases, Russia

Professor Maria Budzinskaya is a retina subspecialist ophthalmologist. She graduated from Russian State Medical University in 1999, completing her residency and postgraduate courses in ophthalmology at the Russian Research Institute of Eye Diseases (“Helmholz”) in 2001. In 2011, Maria Budzinskaya successfully defended her PhD thesis, New diagnostic and treatment approaches of the subretinal neovascular membrane. She has more than 12 years' experience in retinology.

Dr. Budzinskaya is currently participating in multiple international, multicenter clinical trials focused on AMD, vein occlusion, and DME, in some cases as the principal investigator.

She is a member of the Presidium of the Board of the Russian Society of Ophthalmologists and EURETINA. She is also an author of 217 publications in journals and ophthalmology textbooks.

Dr. Andrew Chang

Principal Retinal Specialist, Sydney Retina Clinic and Day Surgery, Australia

Dr. Andrew Chang is a vitreoretinal subspecialist ophthalmologist. He graduated from Sydney Medical School with honors, and underwent registrar training at Sydney Eye Hospital; Royal Victorian Eye and Ear Hospital; Manhattan Eye, Ear and Throat Hospital; and the University of California, Davis. He was awarded a PhD for research into ocular retinal angiography performed in the USA and at the Save Sight Institute, University of Sydney.

Currently, Dr. Chang is a consultant vitreoretinal surgeon and Head of the Retinal Unit at Sydney Eye Hospital. He holds an academic appointment at the Save Sight Institute, University of Sydney, heading the Vitreoretinal Research Group. He is Medical Director of the Sydney Retina Clinic and Day Surgery, and serves as Section Editor of Clinical and Experimental Ophthalmology.

Dr. Chang has various roles in ophthalmic societies; he is Scientific Secretary and founding committee member of APVRS; Chair of the NSW RANZCO committee; and a councillor of Federal RANZCO. His professional awards include the Achievement Award from the APAO and the Teaching Award from RANZCO.

Dr. Chang is involved in basic science and clinical trial research, receiving research grant funding in Australia and the USA. He has authored many peer-reviewed scientific papers in international and Australian journals and book chapters in leading textbooks.

Prof. Woohyok Chang

Chang’s Retina Center, Daegu, South Korea

Dr. Woohyok Chang is a vitreoretinal surgeon with expertise in age-related macular degeneration, diabetic retinopathy, and various surgical retinal diseases. After finishing medical school and a residency at Yeungnam University Hospital, Daegu, South Korea, he undertook fellowships at the Wills Eye Hospital in Philadelphia, Pennsylvania, USA. Dr. Chang then spent 12 years as Head of the Vitreoretinal Service at Yeungnam University Hospital and served as Chair of the Department of Ophthalmology from 2014 to 2015. He recently moved from the university and founded his own retina clinic, Chang’s Retina Center, which operates as an ambulatory surgical center for vitreoretinal surgery.

Dr. Chang was awarded the Allergan Young Researcher Award in 2014 in recognition of his research activities and has received the Rhett Buckler Award in surgical video presentation at the American Society of Retina Specialists Film Festival in two consecutive years (2014–2015). He has published more than 40 papers in peer-reviewed journals and is a member of numerous societies, including the Korean Retina Society, European Vitreoretinal Society, and the American Society of Retina Specialists. Dr. Chang is also a reviewer for a number of international journals and serves on the editorial boards of several retinal journals.

Dr. Martin Charles

Vitreoretinal Specialist and co-director of the Dr. Charles Eye Center, Argentina

In 1999, Martin Charles graduated with honors from medical school at the Universidad del Salvador in Buenos Aires, Argentina. He subsequently trained as a resident at the Fundación Oftalmológica Argentina Jorge Malbràn, where he was elected Chief of Residents, while simultaneously studying to specialize in ophthalmology at the Universidad del Salvador. Following this, Dr. Charles was trained by his father, Dr. Daniel E. Charles, to specialize in anterior segment, retina, and trauma.

During 2006–2007, Dr. Charles achieved his PhD in teacher training to serve as Professor of Ophthalmology at the Universidad del Salvador. In 2006, he founded the “Fundación Ver” with his father to provide help to people in need, and opened a residency program to train young professionals.

Currently, Dr. Charles serves as a vitreoretinal specialist in trauma and anterior segment surgery, practicing a total of 2000 surgical procedures per year. He also acts as Co-Director of the Dr. Charles Eye Center in Buenos Aires, along with his father.

Dr. Charles has presented 217 papers, posters, and photographs in various scientific conferences around the world, which have earned him 33 scientific awards; he has published 11 papers in peer-reviewed journals, and has contributed surgical videos to the textbook Ryan’s Retina (Fifth Edition). Additionally, he has two patents in devices for surgical ophthalmology.

A member of several national societies (including the ASRS, ASCRS, and AAO), as well as local societies (including SARYV, SAO, and CAO), Dr. Charles currently holds executive positions in two of them and was President of the Panamerican Society of Eye Trauma from 2015 to 2017.

Dr. Charles has been the recipient of several awards from the ASRS: he achieved the Honor Award in 2013, the Senior Honor Award in 2014, and the Rhett Buckler Award in 2016 and 2017.

Dr. Lee-Jen Chen

Senior Physician and Chief of the Department of Ophthalmology, Mackay Memorial Hospital, Taiwan

Dr. Lee-Jen Chen is currently senior physician at Mackay Memorial Hospital in Taipei, Taiwan. Following completion of his medical degree from the Chung Shan Medical University in Taichung, Taiwan, he went on to serve 2 years as a naval medical officer. He completed his surgical residency at Chang Gung Memorial Hospital before moving on to an ophthalmology residency at Mackay Memorial Hospital. He then completed a fellowship in retina research at the University of Mississippi Medical Center in Mississippi, USA, before returning to Taipei, where he was appointed Chief of the Department of Ophthalmology in 2009.

Throughout his career, Dr. Chen has been consistently awarded for his teaching, having received the Best Teacher of the Year Award at Mackay Memorial Hospital nine times over the last 10 years. He has authored 14 peer-reviewed articles and has been involved in the organizing and running of five long-term clinical trials. He has been Director of the Taiwan Retina Society since 2011.

Dr. Shih-Jen Chen

Associate Professor at National Yang-Ming University and Section Chief of the Department of Ophthalmology, Taipei Veterans General Hospital, Taiwan

Dr. Shih-Jen Chen graduated from Kaohsiung Medical University in 1987, and completed his residency training in ophthalmology at Taipei Veterans General Hospital in 1989. He subsequently underwent his research fellowship at Wilmer Eye Institute in 1999 with Dr. Mark Humayun and Dr. Eugene de Juan, and achieved a PhD in public health at National Yang-Ming University in 2008.

Dr. Chen is currently Section Chief and full-time staff in the vitreoretinal section of the Department of Ophthalmology, Taipei Veterans General Hospital, and Associate Professor at the School of Medicine in National Yang-Ming University.

His research interests involve the epidemiology of retinal diseases; the diagnosis and treatment of AMD; polypoidal choroidal vasculopathy; myopic maculopathy; diabetic retinopathy; computerized image studies of macular disease; retinal prosthesis; and induced pluripotent stem cells for inherited retinal diseases. Dr. Chen has published more than 60 papers and has been involved in seven clinical trials since 2010, which included PLANET and EVEREST I and II.

Dr. Chen is the current President of the Taiwan Retinal Society.

Dr. Youxin Chen

Vice Director and Professor, Department of Ophthalmology, Peking Union Medical College, China

Dr. Youxin Chen, MD, currently serves as Vice Director and Professor at Peking Union Medical College Hospital, Beijing, China. Dr. Chen graduated from the Third Military Medical University, Chongqing, China, in 1986, and earned his MD from Peking Union Medical College in 1996. He also spent 2 years undertaking postdoctoral research at the Doheny Eye Institute, University of Southern California, USA.

In his practice, Dr. Chen pioneered the research on choroidal angiography in China and accumulated rich experience in diagnosis and treatment of complicated ocular fundus disorder. Photodynamic therapy and anti-VEGF therapy were also part of his area of expertise. In addition, Dr. Chen has been actively engaged in scientific research and clinical trials. The Clinical and Basic Research in Dacryology study won second prize in the National Scientific and Technological Progress Awards, and the international multicenter clinical trials ‘Brilliance’ and ‘VIVID EAST’, in which Dr. Chen served as principal investigator, also achieved satisfactory outcomes.

To date, Dr. Chen has published more than 70 articles in domestic and international journals. He is also the general secretary of the Chinese Ophthalmological Society and Vice President of the Chinese Ophthalmological Association. For his efforts to promote the development of ophthalmology in China and the Asia-Pacific region, Dr. Chen was presented with the Distinguished Service Award and the Achievement Award by the Asia-Pacific Academy of Ophthalmology in 2008 and 2016.

Prof. Catherine Creuzot-Garcher

Professor of Ophthalmology and Chair, University Hospital of Dijon, France

Catherine Creuzot-Garcher is currently Head of the Department of Ophthalmology and is responsible for the outpatient surgical unit at the University Hospital of Dijon, France.

She is a member of the teaching council of the faculty and has been strongly involved in European teaching programs of the European Board of Ophthalmology (EBO) as the French delegate (2004–16). She was Chairman of the Education Committee of the EBO and President of the EBO from 2013 to 2015. She is the French delegate for European University Professors of Ophthalmology (EUPO). Professor Creuzot-Garcher was also President of the Collège des Ophtalmologistes Universitaries de France (COUF) for 8 years and has been a council member of the Société Française d'Ophtalmologie (SFO) since May 2009. She was Vice-Secretary General of the SFO in 2013–15 and President of the SFO in 2016. She was also Secretary General of the European Association for Vision and Eye Research from 2012 to 2016.

She is co-director of the eye, nutrition and signalisation unit of INRA Centre, Dijon. As Head of the Research Pole at the University Hospital since 2012, she deals with all research programs at the hospital and has been coordinator of three national clinical trials (PHRC) dedicated to retinal detachment (DOREFA), diabetic retinopathy (LIGHT), and type 1 macular telangiectasia (TELEMAC) and two regional trials dedicated to endophthalmitis and macular subretinal hemorrhage. She is a consultant for Haute Autorité de Santé and expert adviser for the French Ministry of Health (ANSM) for dry eye disease, allergy, nutrition, age-related macular degeneration (AMD), and diabetic retinopathy since 1999.

She was awarded Chevalier des Palmes Académiques in 2011 and Chevalier de la Légion d’Honneur in 2013.

To date, she has been involved in the development of 220 papers published in peer-reviewed journals and 15 books, and her main fields of interest are surgical retina, diabetic retinopathy, and AMD.

Dr. Alan F. Cruess

Department of Ophthalmology and Visual Sciences, Dalhousie University, Halifax, Nova Scotia, Canada

Dr. Alan Cruess is Professor in the Department of Ophthalmology and Visual Sciences at Dalhousie University, Nova Scotia, Canada. He has completed two 5-year terms as Head of the Department, and as District Chief of Ophthalmology of Capital Health in Nova Scotia (2003–14). Dr. Cruess began his academic career at Queen’s University, where he was appointed Professor and Head of the Department of Ophthalmology from 1992 to 2003.

Dr. Cruess’ main research interest is in clinical trials of new therapies for age-related macular degeneration, diabetic retinopathy, and retinal vascular occlusion. Dr. Cruess has recently been appointed as a principal investigator of the Diabetic Retinopathy Clinical Research Network (DRCR.net), a National Eye Institute U.S.-sponsored network to conduct clinical trials in diabetic retinopathy. Dr. Cruess is a member of the Canadian Medical Association, the Canadian Ophthalmological Society, the Macula Society, the Retina Society, and Club Jules Gonin. He is also a Fellow of the Royal College of Physicians and Surgeons of Canada and of the American Academy of Ophthalmology.

He is a Past President of the Canadian Ophthalmological Society (2006–08) and has served on the Board of Directors of the Pan-American Association of Ophthalmology, and on the Council of the American Academy of Ophthalmology. Dr. Cruess is serving on the Board of the Canadian National Institute for the Blind, and has recently been elected to the Board of Vision Loss Rehabilitation Canada.

Dr. Eduardo Cunha de Souza

Ophthalmologist, Vitreoretinal Department, Universidade Federal de São Paulo, Brazil

Dr. Eduardo Cunha de Souza is an ophthalmologist working in São Paulo, Brazil at the Vitreoretinal Department of the Universidade Federal de São Paulo. After completing his medical training at the Faculdade de Ciências Médicas da Santa Casa de São Paulo, Dr. de Souza achieved his PhD in ophthalmology at the Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo.

Dr. de Souza is a member of numerous ophthalmology societies including Conselho Brasileiro de Oftalmologia, the AAO, the PAAO, the Retina Society, the Association for Research in Vision and Ophthalmology, the ASRS, Schepens Alumni, and Grupo Latino Americano de Angiofluoresceinografia. He is also an invited attendee of the Midwest Ocular Angiography Conference.

Prof. José Cunha-Vaz

Emeritus Professor of Ophthalmology, University of Coimbra, Portugal

José Cunha-Vaz is Emeritus Professor of Ophthalmology of the University of Coimbra, Portugal, and President of the Association for Innovation and Biomedical Research on Light and Image, a non-profit clinical research organization that coordinates the European Vision Institute Clinical Research Network. He is also Editor of Ophthalmic Research.

Professor Cunha-Vaz was Chair and Director of the Department of Ophthalmology at the University of Coimbra Hospital before moving to the University of Illinois in the USA, where he was appointed Professor and Director of the Retina Service. Following his return to Portugal, he created two new institutes dedicated to vision research: the Institute for Biomedical Imaging and Life Sciences, and the Association for Innovation and Biomedical Research on Light and Image.

Professor Cunha-Vaz has authored more than 490 peer-reviewed papers and books. He was elected member of the Academia Ophthalmologica Internationalis (1994) and the European Academy of Ophthalmology (2004). He has received a number of prestigious awards throughout his career, including the Paul Henkind Award from the Macula Society (1998), the Alcon Research Institute Award (1998), the Mildred Weisenfeld Award for Excellence in Ophthalmology from ARVO (2014), and the Albert C. Muse Prize (2014). Professor Cunha-Vaz has also received the Order of Merit and Order of Prince Henry the Navigator from Portugal. He is an honorary member of the Portuguese Society of Ophthalmology, the Spanish Society of Ophthalmology, and the Club Jules Gonin.

Professor Cunha-Vaz’s work has included laboratory and clinical research in retina and intraocular fluids, with a special emphasis on blood–retinal barriers and diabetic retinopathy.

Dr. Patricia D’Amore

Director of the Howe Laboratory (Massachusetts Eye and Ear) and Director of Research, Senior Scientist, and the Ankeny Scholar of Retinal Molecular Biology, Schepens Eye Research Institute, USA

Dr. Patricia D’Amore received a PhD in biology from Boston University and an MBA in finance from Northeastern University in Boston, Massachusetts, USA. She completed research fellowships in ophthalmology and physiological chemistry at Johns Hopkins University School of Medicine in Baltimore, Maryland, USA. In 1981, she joined Dr. Judah Folkman’s laboratory at Boston Children’s Hospital, where she remains a Research Associate in the Department of Surgery.

At Harvard Medical School, Dr. D’Amore is the Charles L. Schepens Professor of Ophthalmology, Vice Chair of Basic Research in the Department of Ophthalmology, and Professor of Pathology. At Massachusetts Eye and Ear, Harvard Medical School, she is Director of the Howe Laboratory, and Associate Chief for Basic and Translational Research. Additionally, she is Director of Research, Senior Scientist, and Ankeny Scholar of Retinal Molecular Biology at Schepens Eye Research Institute, Massachusetts Eye and Ear.

An international expert in vascular growth and development, Dr. D’Amore has been at the forefront of angiogenesis research for more than three decades. She co-discovered the role of VEGF in eye disease, which formed the scientific foundations of anti-VEGF therapies for intraocular vascular diseases such as diabetic retinopathy and AMD. Dr. D’Amore also developed a widely used mouse model of oxygen-induced retinopathy, which serves as the cornerstone of many studies of vascular development and preclinical investigations of vascular-targeting agents. Additionally, Dr. D’Amore uncovered important physiological roles of vascular growth factors, yielding crucial insight into the safe use of anti-angiogenic therapies. Her current research involves the regulation of development and stabilization of the microvasculature, and investigating the role of inflammation in AMD pathogenesis.

Dr. D’Amore was a laureate of the 2014 António Champalimaud Vision Award, and she is the 2015 recipient of the Proctor Medal from ARVO.

Prof. Bora Eldem

Professor of Ophthalmology, Hacettepe University, Turkey

Bora Eldem is Professor of Ophthalmology and Chair of the Ophthalmology Department at Hacettepe University in Ankara, Turkey. He graduated from the same university, where he also completed a medical residency program in their Ophthalmology Department. He became an Associate Professor in 1990, and Full Professor in 1996. He completed his fellowship in the Retinal Diagnostic Department at Moorfields Eye Hospital in London, UK.

Professor Eldem is a member of several international societies, including the American Society of Retina Specialists, ARVO, EVRS, and EURETINA. He has served as a country delegate to the International Council of Ophthalmology, the European Union of Medical Specialists, and the European Board of Ophthalmology. Currently, he is a member of the executive board of the Middle East Africa Council of Ophthalmology. He is also country coordinator and principal investigator on trials related to AMD, DME and RVO, and is President of the Turkish Ophthalmological Society.

Professor Eldem’s main interests include the diagnosis, and medical and surgical treatments, of vitreoretinal disorders, uveitis, and Behçet’s disease.

Dr. Hazem Elsabagh

Consultant and Chief, Vitreoretinal Unit, Magrebi Eye Center, Saudi Arabia

Hazem Elsabagh obtained his Bachelor of Medicine, Bachelor of Surgery (MBBCh) degree from Ain Shams University in Cairo, Egypt in 1988. He received his master’s degree in ophthalmology in 1994, his medical doctorate degree from Benha University in Benha, Egypt in 1999, and undertook a fellowship at the Royal College of Surgeons of Edinburgh in 1999.

Between 1999 and 2002, he undertook another fellowship at the Vitreoretinal Department of Magrabi Eye and Ear Hospital in Jeddah, Saudi Arabia. Since 2002, he has been a consultant and Chief of the Vitreoretinal Unit at Magrabi Eye Center in Dammam, Saudi Arabia.

Dr. Elsabagh is currently a reviewer for the British Journal of Ophthalmology and the Egyptian Retina Journal, and serves as an examiner for the Royal College of Surgeons of Edinburgh. He also has several publications in peer-reviewed journals.

Dr. José Juan Escobar Barranco

Chair of the Ophthalmology and Research Departments, Dos de Maig Hospital, Spain

Dr. José Juan Escobar Barranco is Chair of the Ophthalmology and Research Departments in Dos de Maig Hospital in Barcelona, Spain. He graduated in medicine and surgery from the University of Barcelona and completed his specialization at the Hospital Clinic of Barcelona.

Dr. Escobar Barranco is a member of the European Vision Institute Clinical Research Network, EURETINA, the Spanish Society of Retina and Vitreous, and the Catalan Society of Ophthalmology. He is also a scientific advisor to several expert groups in retinal pathology. He has authored several books and chapters, particularly on diabetic retinopathy and DME, and has written many clinical guides and technical papers for the Healthcare Department of the Generalitat de Catalunya. Dr. Escobar Barranco has contributed to numerous articles in renowned national and international journals, as well as for national and international society meetings.

Dr. Escobar Barranco specializes in retina practice and vitreoretinal surgery, particularly in patients with DME, diabetic retinopathy and AMD, and has participated in several multicenter international clinical trials.

Prof. Nicole Eter

Professor and Chair, University Hospital Münster, Germany

Nicole Eter is Professor of Ophthalmology and Chair of the Department of Ophthalmology, University of Münster, Germany. She attended medical school at the University of Bonn, Germany, and completed her residency in ophthalmology at the Department of Ophthalmology, University of Bonn Medical Center. Her clinical interests include diagnostics and therapy of diseases of the anterior and posterior eye segment; vitreoretinal, cataract and glaucoma surgery; corneal transplantation; surgery of the ocular adnexa; and laser surgery of the anterior and posterior segment.

Since 2012, Professor Eter has been a member of the Quality Assessment Committee of the Association of Statutory Health Insurance Physicians, Westphalia; a member of the Board of Examiners of the Medical Association, Westphalia; and a member of the executive committee of the German Retina Society. Additionally, she is a member of the board of directors of the German Scientific Association of Ophthalmology, and Vice Chair of the Association of Department Chairs in Ophthalmology.

In addition to being an editorial board member and a reviewer for multiple scientific journals, Professor Eter has authored more than 100 papers in peer-reviewed journals and 6 book chapters. She has also given more than 500 scientific presentations.

Professor Eter’s major scientific interests are in pathogenesis and therapy of AMD; cellular imaging; stimulation and inhibition of proliferation in cell culture models; and therapeutic options of nanotechnology in neovascular eye diseases.

Dr. Marc Evans

Consultant Physician in Diabetes and Endocrinology, University Hospital Llandough, Wales

Dr. Marc Evans is a consultant physician in diabetes and endocrinology at University Hospital Llandough in Cardiff, Wales. Previously, he was a consultant diabetologist at University Hospital Llandough and the University Hospital of Wales, and a lecturer in diabetes and endocrinology at the University of Wales College of Medicine.

Dr. Evans has considerable involvement and interest in ongoing medical education related to diabetes care and has published more than 200 articles, book chapters, and abstracts. He is currently Editor-in-Chief of Diabetes Therapy.

Dr. Evans has multiple ongoing academic and clinical interests, including the pathophysiology of vascular disease in type 2 diabetes and the clinical physiology of the natural history of type 2 diabetes. He is also interested in the health economics of diabetes care and health outcomes in people with type 2 diabetes.

Dr. Michael Fielden

Associate Clinical Professor, University of Calgary and Partner at Calgary Retina Consultants, Canada

Dr. Fielden is a Calgary Retina Consultants partner at the Southern Alberta Eye Centre and is an Associate Clinical Professor at the University of Calgary. He has a busy clinical retinal practice and performs all medical retinal procedures in the office, including laser treatment and ocular injections. He has a special interest in diabetic retinopathy and age-related macular degeneration. He participates in medical student, resident, and fellow education. Dr. Fielden frequently gives lectures to a variety of healthcare professionals, including at international retina meetings. He actively participates in clinical research as a principal investigator and has numerous peer-reviewed publications and book chapters.

Dr. Fielden is the past president of the Retina Society of Alberta, and is a member of the Alberta Medical Association, Canadian Medical Association, Canadian Ophthalmological Society, and the American Society of Retina Specialists. He is a fellow of the Royal College of Physicians and Surgeons of Canada and is a diplomate of the American Board of Ophthalmology.

Prof. Marta S. Figueroa

Professor at the University of Alcalá de Henares, Spain

Professor Marta S. Figueroa is the Medical Director of Vissum Madrid. She is also Chief of the Vitreoretinal Department at the University Hospital Ramón y Cajal, Principal Investigator of the Ramón y Cajal Health Research Institute, and Professor at the University of Alcalá de Henares.

After studying medicine at Complutense University, Professor Figueroa completed a residency in ophthalmology at the University Hospital Ramón y Cajal; she subsequently achieved her PhD degree from the University of Alcalá de Henares.

Professor Figueroa has been President of the Retinaplus+ Foundation since 2014 and she is former President of the Spanish Vitreoretinal Society, where she is currently a member of the board.

Professor Figueroa’s main areas of expertise are retinal detachment, diabetic retinopathy, macular surgery, trauma, AMD, vein occlusions, and high myopia. She is the author of more than 150 publications in peer-reviewed journals and textbooks. Professor Figueroa has given more than 500 conferences on different surgical and medical topics and serves on several editorial boards, in addition to holding the position of Associate Editor of the Journal of VitreoRetinal Diseases.

Dr. Kenneth Fong

Vitreoretinal Surgeon, Sunway Medical Centre, Malaysia

Dr. Kenneth Fong graduated from the University of Cambridge in 1998 and completed his ophthalmology training in London, followed by vitreoretinal surgery fellowships in Cheltenham, UK and Royal Perth Hospital, Australia. He was appointed Associate Professor at the University of Malaya (UM) from 2009–12 and founded the UM Eye Research Centre. He is currently the President of the Malaysian Society of Ophthalmology and Council Member of the Asia-Pacific Vitreo-retina Society (APVRS).

Dr. Fong has published more than 40 scientific papers in international journals, as well as book chapters on cataract surgery. He also co-authored a book called Food For Your Eyes to raise awareness of age-related macular degeneration (AMD). This book was awarded Best Health Cookbook in the world by the Gourmand World Cookbook Awards in Paris in 2013.

He is highly sought after as a speaker in local and international meetings and has been interviewed extensively on the radio and TV. He recently gave a prestigious TED talk to more than 5000 people in Kuala Lumpur. He is very passionate about the prevention of blindness in the community and organized the first ever national-level Retinal Diseases Awareness Week in Malaysia in 2013 to raise awareness of AMD and diabetic retinopathy in the public.

Dr. Jans Fromow Guerra

Professor of Cellular and Tissue Biology (Faculty of Medicine) and Professor of Ophthalmology (National Autonomous University of Mexico), Facultad Medicina UNAM, Mexico

Dr. Jans Fromow Guerra, former Professor of Cellular and Tissue Biology, is currently professor in the master and doctor degree program at the Faculty of Medicine in the National Autonomous University of Mexico (UNAM) and Professor of Ophthalmology at the same institution. He graduated summa cum laude from UNAM before completing his specialization in ophthalmology and his fellowship in retina and vitreous surgery at the Association for the Prevention of Blindness in Mexico and UNAM.

Dr. Fromow Guerra is an active member of the Mexican Society of Ophthalmology, the Mexican Council of Ophthalmology, the Mexican Retina Association, AAO, ARVO, EVRS, PAAO, and the American Society of Retina Specialists, from which he received an Honor Award in 2006 and a Senior Honor Award in 2008.

In 2006, Dr. Fromow Guerra was a founding member of the Pan-American Collaborative Retina Study Group, and in 2010 he was a founding member of the México Colegio Nacional de Investigación en Ciencias Visuales (MARVO; part of the ARVO International Chapter Affiliates Program). He served as President of the Mexican Retina Association in 2013 and President of MARVO from 2013 to 2015. He is currently Researcher Level I in the Mexican National System of Researchers.

Dr. Fromow Guerra has published more than 40 original scientific papers and book chapters. His main topics of interest and research are focused on the clinical and surgical aspects of retinal diseases, especially in the fields of molecular biology, clinical epidemiology, nutrition, imaging, and the development of diagnostic scales. He heads the first probabilistic population study of prevalence of ocular diseases and a study of validation of telemedicine for the early diagnosis of blinding diseases.

Mr. Richard Gale

Consultant Ophthalmologist, Hull York Medical School, UK

Mr. Richard Gale is a Consultant Medical Ophthalmologist practicing at York Teaching Hospital, UK. He trained in Yorkshire, Cambridge and London (at Moorfields and St. Thomas’), and for a short period in Boston, Massachusetts, USA. His interests are in medical disorders of the retina and inflammatory eye disease. He has been awarded ‘best clinical service’ by the Macular Society.

Mr. Gale’s PhD was in the field of imaging and therapeutics in macular degeneration. He has been the chief or principal investigator on approximately 20 research studies, recruiting more than 500 participants. He has been awarded a number of personal grants for research and has published around 50 papers or book chapters.

Mr. Gale has a keen interest in education, chairing the Medical Ophthalmology Specialist Advisory Committee and a national assessment panel for the Medical Royal Colleges. He is an honorary senior lecturer at the Hull York Medical School.

Prof. Horst Helbig

Professor and Director, Universitätsklinikum Regensburg, Germany

Professor Horst Helbig is Past-President of the German Ophthalmological Society and Vice Dean of the Faculty of Medicine at the University of Regensburg, Germany. He first studied medicine at the University of Berlin, where he then received training in both physiology and ophthalmology; he also completed research fellowships at Yale University, Uppsala University, and the National Eye Institute.

Professor Helbig was Head of the Retina Service at both Cantonal Hospital, St. Gall, and University Hospital Zurich. In addition, he holds a Master Degree of Health Service Administration at St. Gall. He is now Director and Professor at the University Eye Hospital, Regensburg, and is on the executive board for the German Retina Society.

Prof. Frank G. Holz

Professor and Chair of the Department of Ophthalmology, University of Bonn, Germany

Frank G. Holz is Professor and Chair of the Department of Ophthalmology at the University of Bonn, Germany. He trained at the University of Heidelberg, Germany, and completed a fellowship at Moorfields Eye Hospital, London, UK, with Professor Alan Bird. Professor Holz was a co-founder of the German Research Foundation Priority Program for AMD and the GRADE Reading Center in Bonn. He is a board member of the German Ophthalmological Society and EURETINA; a member of the European Academy of Ophthalmology, the Macula Society, the Club Jules Gonin, and the Gass Club; Editor-in-Chief of Der Ophthalmologe; and serves as a reviewer for many peer-reviewed journals.

Professor Holz has received numerous awards, including the Leonhard Klein Award for Ocular Surgery, the Alcon Research Institute Award, the Senior Achievement Award from the AAO, and the Jules Gonin Award. He has published more than 400 articles in peer-reviewed journals and is Editor of several books on retinal diseases and retinal imaging.

Professor Holz’s major clinical interest is surgical and medical retina. His scientific interests include the pathogenesis, prognostic factors, biomarkers and treatment of macular and retinal diseases, and innovative retinal imaging technologies.

A./Prof. Alex Hunyor

Associate Professor of Ophthalmology, University of Sydney, Sydney, Australia

Associate Professor Alex Hunyor is a retinal specialist with expertise in vitreoretinal surgery and macular disease. He graduated with Honors from Sydney University Medical School in 1990 and trained in ophthalmology at the Royal Victorian Eye and Ear Hospital (RVEEH) in Melbourne. He was awarded both the Cedric Cohen and Ken Howsam Medals for excellence in the Royal Australian and New Zealand College of Ophthalmologists (RANZCO) examinations, and the RANZCO-ARVO and RANZCO-Sigma Scholarships. He then undertook 3.5 years of subspecialty training in medical and surgical retina at RVEEH, the Casey Eye Institute (Portland, USA), and Vanderbilt University (Nashville, USA). He returned to practice in Sydney in 2000.

Associate Professor Hunyor is a Clinical Associate Professor of Ophthalmology and member of the Macular Research Group at the Save Sight Institute, University of Sydney. He is involved in numerous clinical trials for treatment of retinal diseases and is one of the principal investigators in the Australian Macular Hole Study and the Fight Retinal Blindness project.

He is a member of the Australian and New Zealand Society of Retinal Specialists, Oceania Retina Association, American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, and the American Society of Retina Specialists (for which he is the Australian international delegate). Associate Professor Hunyor is Chair of the Medical Board of the Macular Degeneration Foundation and a Governor on the Board of the Sydney Eye Hospital Foundation.

Associate Professor Hunyor is a past examiner for the RANZCO Advanced Clinical Examinations, a member of the RANZCO Medicare Advisory Committee, and is involved in teaching of local ophthalmic trainees and ophthalmologists, as well as participating in education of overseas specialists through the RANZCO International Development Programme. He has received the RANZCO Award for Excellence in Training on five occasions. Associate Professor Hunyor has given many lectures at local and international scientific meetings, has over 50 peer-reviewed publications, and serves as a reviewer for several ophthalmic journals as well as the Medical Journal of Australia.

Prof. Dr. Antonia M. Joussen

Professor and Chair of Ophthalmology, Charité – University Medicine Berlin, Germany

Professor Dr. Antonia M. Joussen is a vitreoretinal surgeon. She holds a Chair position in ophthalmology at the Charité – University Medicine Berlin in Germany at two campuses, Campus Virchow-Klinikum and Campus Benjamin Franklin.

After attending medical school in Heidelberg, Vienna and London, she received her PhD from the University of Heidelberg in 1996. During her ophthalmology residency at the University of Heidelberg and RWTH Aachen University, Germany, she performed a research fellowship at the Boston Children’s Hospital in Massachusetts, USA. In 2000, she was appointed as an instructor at Massachusetts Eye and Ear, Harvard Medical School. After returning to Germany, she received the Emmy Noether Career Development Grant (Scientific Excellence Program) from the German Research Foundation from 2002 to 2007.

While building her research group in the field of ocular angiogenesis, Professor Dr. Joussen received her vitreoretinal training with Professor Dr. Bernd Kirchhof at the University of Cologne. In 2006, when she was appointed Full Professor and Chair of Ophthalmology at the Universities of Regensburg, Göttingen and Düsseldorf, she chose to continue her work at the University of Düsseldorf, building the retina subspecialty and modernizing the pre-existing cornea focus of the department. In 2010, she rejected an appointment to chair the Department of Ophthalmology of the University of Heidelberg and moved to Berlin.

Professor Dr. Joussen’s research group in Berlin has expanded the vitreoretinal focus of the department with the addition of an ocular oncology subspecialization. She carries out basic research on angiogenesis and diabetic retinopathy and has published more than 200 research articles. She also serves as Editor-in-Chief for Graefe’s Archive for Clinical and Experimental Ophthalmology.

Mr. David Keegan

Consultant Vitreoretinal Surgeon and Head of Department, Mater Misericordiae University Hospital, Ireland

David Keegan is Consultant Vitreoretinal Surgeon and Head of Department at the Mater Misericordiae University Hospital, Dublin. He is also National Clinical Lead for Diabetic Retinopathy at the National Screening Service, Dublin, which is a new, government-funded screening program in Ireland that offers free, regular diabetic retinopathy screening to people with diabetes aged 12 years and older. He also runs the Mater Inherited Retinal Degeneration Service along with the Retinal Clinical Trials Unit.

Mr. Keegan is a graduate of the Royal College of Surgeons in Ireland, having qualified in 1994. He attained his PhD in retinal transplantation from University College London (supervised by Ray Lund), and completed his basic and higher surgical training at Moorfields Eye Hospital, London (1997–2005). Mr. Keegan followed that with a fellowship in vitreoretinal surgery at Columbia University/New York Presbyterian Hospital, New York (2005–2006) with Dr. Stanley Chang.

Mr. Keegan serves on the board of both the National Council for the Blind of Ireland and Fighting Blindness Ireland. In addition, he is actively involved in helping professionals in different countries to share knowledge; he is Chair of the Low Vision Working Group and sits on the coordinating committee of the European Reference Network Rare Eye disease group.

Dr. Peter Kertes

Ophthalmologist-in-Chief, Sunnybrook Health Sciences Centre, Canada

Dr. Peter Kertes is currently a vitreoretinal surgeon and the Ophthalmologist-in-Chief of the John and Liz Tory Eye Centre at the Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada. He is also on staff at the Hospital for Sick Children, and is Professor of Ophthalmology and Vision Sciences at the University of Toronto. He studied molecular biology at Princeton University in New Jersey, USA, and then went to McGill University Medical School in Montreal, Quebec, Canada. He then completed a residency in ophthalmology at the University of Ottawa and undertook a 2-year vitreoretinal surgical fellowship at Louisiana State University.

Dr. Kertes has an interest in clinical epidemiology and evidence-based medicine, and has published 3 books on the major clinical trials in ophthalmology. He also served as Editor-in-Chief of the journal Evidence-Based Ophthalmology, has authored many chapters in textbooks, and has contributed to more than 65 peer-reviewed publications.

Dr. Kertes has a special interest in international ophthalmology and has participated in more than 20 volunteer projects throughout the developing world.

Prof. Laurent Kodjikian

Professor of Ophthalmology and Chair (University of Lyon) and Associate Chair of the Department of Ophthalmology (Croix-Rousse University Hospital), France

Laurent Kodjikian is Professor of Ophthalmology (first class) and Chair of the University of Lyon, France, and Associate Chair of the Department of Ophthalmology at Croix-Rousse University Hospital in Lyon.

Since 2005, Professor Kodjikian has been on the boards of the National Security Agency for Medicines and Health Products, and the French National Authority for Health. He has also been an expert on clinical research projects in university hospitals for the French Health Minister and an administrator of the French Society of Ophthalmology. He is also a member of numerous scientific societies (ARVO, AAO, EURETINA, the Club Jules Gonin, and the French Society of Ophthalmology).

Professor Kodjikian has contributed to more than 170 publications in the ophthalmic literature and is the author or co-author of 8 books. He is a reviewer for 31 journals and currently belongs to the editorial board of the Journal of Ophthalmology, the International Journal of Ophthalmology, Clinical Research, and Journal Français d’Ophtalmologie.

Professor Kodjikian’s research focus is on medical and surgical retina (especially AMD, diabetic retinopathy, and RVO) and in infections and inflammations (uveitis). He was the principal coordinator of the national GEFAL study and has been involved in more than 40 clinical trials, examining novel therapies for AMD and diabetic retinopathy.

Dr. Adrian Koh

Senior Consultant, Eye & Retina Surgeons, Singapore

Dr. Adrian Koh is founding partner and senior consultant at the Eye & Retina Surgeons, Camden Medical Centre, Singapore, and Director of Retinal Centre International. He is visiting consultant to the Vitreoretinal Service, Singapore National Eye Centre, Singapore Eye Research Institute, National University Hospital Services, and Tan Tock Seng Hospital, Singapore. He is past President of the Singapore Society of Ophthalmology; member of the Executive Council of the College of Ophthalmologists, Singapore; and sits on the council of APAO and APVRS. He is the Founding Chair of and honorary advisor to Retinitis Pigmentosa Society Singapore, and was recently appointed Executive Director of ESASO Asia. He was Congress Secretary General and Vice President of the APAO Congress 2006 in Singapore, and Congress President of the 5th APVRS in 2010. He is an active member of the Macula Society and the Club Jules Gonin.

Dr. Koh completed fellowships in medical retina at Moorfields Eye Hospital and the UCL Institute of Ophthalmology, London, UK (1998–1999), and at the Jules Stein Eye Institute, UCLA, Los Angeles, California, USA (1999–2000). The recipient of numerous prestigious awards, Dr. Koh has authored or edited many publications in the field of ophthalmology.

Dr. Koh’s areas of expertise include degenerative macular diseases such as choroidal neovascularization, inherited retinal dystrophy, visual electrophysiology, fundus angiography, and retinal vascular disease. Dr. Koh was one of the first surgeons to introduce photodynamic therapy in the Asia-Pacific region, and he sits on several international advisory boards and steering committees for various clinical trials.

Prof. Mineo Kondo

Chair of the Department of Ophthalmology, Mie University Graduate School of Medicine, Japan

Professor Mineo Kondo is Chair of the Department of Ophthalmology at the Mie University Graduate School of Medicine. He graduated from Kanazawa University School of Medicine in 1991 and received his doctoral degree in ophthalmology from Nagoya University in 2007. From 1999–2001 he undertook a research fellowship at the University of Michigan in Ann Arbor, and joined the faculty of the Department of Ophthalmology at Nagoya University in 2001.

Professor Kondo is an active clinician scientist who has continuously published original experimental and clinical studies on the retina and macula. His special interest is the physiology of the retina in normal and diseased eyes, and he has used electrophysiological, morphological, and molecular biological techniques to diagnose and characterize eyes with retinal diseases.

With more than 200 peer-reviewed publications, Professor Kondo currently serves on the editorial boards of four scientific journals: Translational Vision Science and Technology (Associate Editor), Documenta Ophthalmologica (Associate Editor), Current Eye Research, and Japanese Journal of Ophthalmology.

Prof. Jean-François Korobelnik

Professor of Ophthalmology in Vitreoretinal Surgery and Head of the Ophthalmology Department, University Hospital of Bordeaux, France

Jean-François Korobelnik is Professor of Ophthalmology in Vitreoretinal Surgery and Head of the Ophthalmology Department at the University Hospital of Bordeaux, France. He completed his medical training at University Paris VII in 1985, was awarded a Master of Science (Diplome d’Etudes Approfondies) in 1989, completed his fellowship at Hotel-Dieu of Paris, and has held his professorship in Bordeaux since 1999.

Professor Korobelnik is a member of several societies, including the French Society of Ophthalmology, AAO, ARVO, the American Society of Retina Specialists, EURETINA, the European Association for Vision and Eye Research, and the Club Jules Gonin. He regularly participates in expert advisory board meetings for pharmaceutical organizations, and was President of the French Society of Ophthalmology from May 2013 to May 2015.

Professor Korobelnik is involved in clinical research that mainly focuses on eye disease epidemiology (E3 Consortium), macular diseases (AMD, DME, etc.), and retinal detachment. He is the author or co-author of more than 160 scientific publications.

Dr. Anthony Kwan

Director of Vitreoretinal Surgery, Queensland Eye Institute, Australia

Dr. Anthony Kwan is Director of Vitreoretinal Surgery at the Queensland Eye Institute, South Brisbane, Australia; Director of Ophthalmology at the Mater Health Services (Brisbane); and Director of the Queensland Electro-Diagnostic and Imaging Centre. He has been Chair of the Australian and New Zealand Society of Retinal Specialists since 2013.

Dr. Kwan was educated in the UK, and undertook his ophthalmology training at Moorfields Eye Hospital in London. He obtained his postgraduate research doctorate (MD) at the UCL Institute of Ophthalmology, London, in experimental retinal transplantation, under the supervision of Professor Alan Bird and Professor Raymond Lund. He was fellowship-trained at the Lions Eye Institute in Perth, Australia, and at Moorfields Eye Hospital.

Dr. Kwan holds the academic title of Associate Professor of Ophthalmology from the University of Queensland and has published widely in both clinical and scientific journals. He received grants from the Wellcome Trust and MRC in the UK, and from the Ophthalmic Research Institute of Australia, Macular Disease Foundation Australia, and NHMRC in Australia. He specializes in both medical and surgical retinal diseases.

Dr. Timothy Lai

Honorary Clinical Associate Professor (Chinese University of Hong Kong) and Director (2010 Retina and Macula Centre), Chinese University of Hong Kong and Affiliated Institutes, Hong Kong

Dr. Timothy Lai is an Honorary Clinical Associate Professor at the Department of Ophthalmology and Visual Sciences at The Chinese University of Hong Kong, and Director of the 2010 Retina and Macula Centre, Hong Kong.

As one of the leading experts in vitreoretinal diseases in the Asia-Pacific region, Dr. Lai has published more than 180 papers in international peer-reviewed journals, and co-authored and edited 7 textbooks. He has also delivered numerous lectures worldwide and has received several international ophthalmic awards, including the Nakajima Award from the APAO and the Achievement Award from the AAO. Dr. Lai serves on the editorial boards of 10 international ophthalmic journals, with roles including Assistant Editor of Retina, Section Editor of Eye, and Section Editor of Clinical and Experimental Ophthalmology.

Dr. Lai’s clinical and research interests lie in the medical and surgical management of retinal diseases, particularly polypoidal choroidal vasculopathy, central serous chorioretinopathy, myopic maculopathy, diabetic retinopathy, choroidal neovascularization, visual electrophysiology, genetics of retinal diseases, and uveitis.

Prof. Paolo Lanzetta

Chair of the Department of Ophthalmology (University of Udine) and Scientific Director of the European Institute of Ocular Microsurgery, Italy

Professor Paolo Lanzetta is Chair of the Department of Ophthalmology at the University of Udine, and Scientific Director of the European Institute of Ocular Microsurgery (IEMO) in Udine, Italy.

Professor Lanzetta is actively involved in retinal clinical research and is currently an investigator in many international, multicenter clinical trials on photodynamic therapy, anti-angiogenic therapies, and new drugs and delivery systems. With surgical experience in anterior and posterior segment procedures and laser treatments, Professor Lanzetta has given more than 350 presentations at national and international meetings. He is a member of numerous professional societies, including ARVO and the Macula Society.

As well as publishing more than 170 original articles, Professor Lanzetta is a scientific reviewer for many journals and serves on the editorial board of the European Journal of Ophthalmology. His main areas of activity are laser applications in ophthalmology; diagnosis and treatment of retinal, vitreous, and macular diseases; and cataract surgery.

Dr. William Li

President, Medical Director, and Co-founder of the Angiogenesis Foundation, USA

Dr. William W. Li received his AB with honors in biochemistry from Harvard College, Cambridge, Massachusetts, USA, and his MD from the University of Pittsburgh School of Medicine in Pennsylvania, USA. He completed his residency training and clinical fellowship in general internal medicine at the Massachusetts General Hospital (a Harvard teaching hospital). Dr. Li is President, Medical Director, and Co-founder of the Angiogenesis Foundation, a non-profit organization that is re-conceptualizing global disease fighting.

A protégé of medical pioneer Dr. Judah Folkman, Dr. Li has been engaged in translational research and clinical applications of angiogenesis-directed therapeutics in ophthalmology, cancer, wound and tissue repair, cardiovascular diseases, neurodegeneration, and other pathologies. A major part of Dr. Li’s work focuses on defining the value of current treatment on patient outcomes and in population health, and identifying new targets and pathways for future innovations in managing and preventing angiogenesis-dependent conditions.

Dr. Li is a sought-after expert collaborator with government agencies, professional societies, industrial and academic innovators, and health policy groups. His non-profit work has been cited by The New York Times, Fortune, and CNN. He has been a speaker at a TED conference, is a member of the Clinton Global Initiative, and has designed a session at the World Economic Forum. He is on the boards of the Angiogenesis Foundation, American College of Wound Healing and Tissue Repair, Plantrician Project, True Health Coalition, and Wound Research Foundation. Dr. Li has served on faculties at Harvard Medical School, Tufts University, and Dartmouth Medical School. He has numerous papers in Science, Nature Reviews, the New England Journal of Medicine, The Lancet, and other leading peer-reviewed medical journals.

Prof. Xiaoxin Li

Chair and Professor of the Eye Center and Eye Institute, Peking University People’s Hospital, China

Professor Xiaoxin Li is Chair and Professor of the Eye Center and Eye Institute of Peking University People’s Hospital in Beijing, China. She is an academic committee member, and Dean of the ophthalmology faculty, of Peking University Health Science Center, Beijing. She is Honor President of the Chinese Ophthalmological Society, past President of the Chinese Ocular Fundus Society, and President of APVRS.

Professor Li has contributed significantly to ophthalmic training and education, especially in the vitreoretinal field in China. She has organized numerous vitreoretinal lectures, seminars, workshops, and courses over the past two decades. She edited the Chinese book ‘Surgery on Vitreous and Retina’, and served as Chapter Editor for Vitreous Diseases, Retina Diseases and Retinal Detachment, and in many other ophthalmology books in China, including a chapter on polypoidal choroidal vasculopathy in Retina (a book edited by Stephen Ryan).

Professor Li has been conducting research for 20 years and has authored or co-authored more than 200 papers in Chinese and international journals.

Dr. Lyndell L. Lim

Senior Research Fellow (University of Melbourne) and Head of the Ocular Immunology Clinic (Royal Victorian Eye and Ear Hospital), Australia

Dr. Lyndell L. Lim is a Senior Research Fellow at the Centre for Eye Research Australia, University of Melbourne, Australia, where she heads the Clinical Trials Research Unit. She is also Head of the Ocular Immunology Clinic at the Royal Victorian Eye and Ear Hospital in East Melbourne, and works as a consultant ophthalmologist specializing in medical retina and ocular inflammatory diseases at both the Royal Victorian Eye and Ear Hospital and the Royal Melbourne Hospital.

Dr. Lim received her medical degree (MBBS) from the University of Melbourne, and completed her ophthalmology training at the Royal Victorian Eye and Ear Hospital. She is dual fellowship–trained in the fields of both medical retina and uveitis, and completed her uveitis fellowship at the Casey Eye Institute in Portland, Oregon, USA, with a particular focus on the use of biologics in inflammatory eye diseases.

Dr. Lim has authored more than 50 peer-reviewed published articles and 5 book chapters. She serves as the Uveitis Section Editor for Clinical and Experimental Ophthalmology, and is Chair of the RANZCO Uveitis Special Interest Group.

Prof. Anat Loewenstein

Chair of the Department of Ophthalmology (Tel Aviv Sourasky Medical Center) and Full Professor of Ophthalmology and Vice Dean of the Faculty of Medicine (Tel Aviv University), Israel

Professor Anat Loewenstein is Chair of the Department of Ophthalmology at the Tel Aviv Sourasky Medical Center, and Full Professor of Ophthalmology, Incumbent of the Sydney A. Fox Chair in Ophthalmology, and Vice Dean of the Faculty of Medicine at Tel Aviv University in Israel. After studying medicine at the Hebrew University of Jerusalem, Israel, she completed a residency in the Department of Ophthalmology at the Tel Aviv Sourasky Medical Center. She then carried out a fellowship in retinal vascular diseases and vitreoretinal surgery at the Johns Hopkins Hospital in Baltimore, Maryland, USA.

Professor Loewenstein carries multiple international leadership positions. She was recently appointed General Secretary of the EURETINA board, is the international representative to the board of the American Society of Retina Specialists, and represents Israel on the European Society of Ophthalmology board. She is also a member of the international committee in the Macula Society board, and was recently granted a Chair in the Academia Ophthalmologica Internationalis.

Professor Loewenstein’s main areas of expertise are AMD, RVO, and the investigation of drug toxicity to the retina. She is the author of 280 publications in peer-reviewed journals and textbooks of ophthalmology, and serves on several editorial boards, in addition to being the Editor of Case Reports in Ophthalmology. She has also led the development of novel technology for early detection of AMD.

Dr. Monica Lövestam-Adrian

Head of the Medical Retina Department (Lund University Hospital) and Associate Professor in Ophthalmology (Lund University), Sweden

Dr. Monica Lövestam-Adrian is Head of the Medical Retina Department at Lund University Hospital and Associate Professor in Ophthalmology at Lund University, Sweden. Previously, Dr. Lövestam-Adrian worked as a senior academic consultant at King Khaled Eye Specialist Hospital in Riyadh, Saudi Arabia, before returning to Sweden to undertake her current position.

Dr. Lövestam-Adrian has an interest in education and, on behalf of the Swedish Ophthalmologic Association, is an investigator of the quality of the Swedish education system in ophthalmology. She is also a member of the steering committees of the Swedish and Danish Medical Retina Clubs.

Dr. Lövestam-Adrian has a special interest in diabetic retinopathy and completed her PhD thesis on the medical risk indicators and treatment outcomes in patients with type 1 diabetes and diabetic retinopathy. Her current research focuses on the assessment of retinal function in diabetic retinopathy by electroretinography (ERG) and multifocal ERG.

Prof. Edoardo Midena

Professor of Visual Apparatus Diseases and Director of the Ophthalmology Clinic and School of Ophthalmology, Padua Hospital, Italy

Professor Edoardo Midena graduated in medicine and surgery, and received his PhD from the University of Padova, Italy. He is board certified in ophthalmology, and is Full Professor of Ophthalmology and Visual Sciences at the University of Padova, School of Medicine, and Chair of the Department of Ophthalmology, Padova University Hospital.

Professor Midena is a member of the scientific board of the G. B. Bietti Foundation in Rome Italy. He is elected member of the Club Jules Gonin, the Retina Society, the Macula Society, and the European Academy of Ophthalmology; fellow of the ARVO and the European Board of Ophthalmology (EBO); and General Secretary of the EBO. He is also an active member of the AAO, EURETINA, EVER, and ISOO; General Secretary of the Italian Retina Society; and consultant on visual disorders for the Italian Ministry of Health.

Professor Midena’s major scientific interests are chorioretinal diseases, ocular oncology, and diagnostic techniques in ophthalmology. His interest in retinal diseases has been devoted to chronic acquired diseases, investigated from bench to bedside. Professor Midena has contributed to the knowledge of the effects of different treatment modalities on retinal and choroidal circulation, and on retinal function. He has also particularly worked on new diagnostic techniques, such as microperimetry, fundus autofluorescence, indocyanine green angiography and confocal microscopy applied in the different fields of ophthalmology. He is recipient of the European Society of Ophthalmology European Leadership Development Program in Ophthalmology and the Achievement Award from the AAO.

Prof. Paul Mitchell

Professor of Ophthalmology (University of Sydney/Westmead Millennium Institute) and Director of Ophthalmology (Sydney West Local Health Network), University of Sydney and Affiliated Institutes, Australia

Paul Mitchell is Professor of Ophthalmology at the University of Sydney (Westmead Millennium Institute), based at Westmead Hospital in Sydney, Australia. He works as a medical retina specialist, is Director of Ophthalmology for the Sydney West Local Health Network, and heads a retina practice (Sydney West Retina). His clinical focus is the management of AMD and diabetic retinopathy (particularly using anti-VEGF therapy) and other vascular retinopathies, and in evaluating ocular effects of systemic diseases.

Professor Mitchell has co-authored 900 papers in peer-reviewed journals, plus 75 books, chapters or letters, and currently has ~37,000 citations to his work. He has been the recipient of many awards and prizes, and served as an ARVO Trustee and as ARVO Vice President. He was the principal investigator on the Blue Mountains Eye Study and other major epidemiological studies of eye disease and vision impairment.

Professor Mitchell has a strong interest in the development, evaluation and application of evidence-based treatment guidelines in ophthalmology, particularly in new therapies for AMD, diabetic retinopathy / macular edema and RVO, and for other retinal diseases. He was a senior investigator, and enrolled patients in many pivotal randomized clinical trials in medical retina, including many recent studies.

Dr. Jordi M. Monés

Director, Centro Médico Teknon, Spain

Dr. Jordi M. Monés, MD, PhD, is an ophthalmologist, macula and vitreoretinal specialist, and researcher. He has been Director of the Institut de la Màcula since 2007, and Director, and one of the founder governors, of the Barcelona Macula Foundation: Research for Vision since 2011. He has been Coordinator of Ophthalmology at the Centro Médico Teknon since 2010.

Dr. Monés earned his medicine and surgery degree and his PhD cum laude in medicine and surgery at the University of Barcelona. He specialized in ophthalmology at the Barraquer Ophthalmology Center (Autonomous University of Barcelona). He obtained his retina specialist degree at Massachusetts Eye and Ear, Harvard Medical School, and at Hospital San José at the Monterrey Institute of Technology and Higher Education.

For the last 20 years, Dr. Monés has been a researcher and principal investigator in most international multicenter clinical trials for the treatment of AMD. He is currently participating in 15 clinical trials and in 3 major European Union projects that have received funding from the European Union’s Horizon 2020 program.

Dr. Monés is a member of the steering committees of the BRIGHTER and CRYSTAL trials, as well as the PROXIMA trial, and is on the advisory boards of many pharmaceutical companies. He is an active member of various scientific advisory societies, including the Macula Society, the Retina Society, the Club Jules Gonin, the American Society of Retina Specialists, AAO, ARVO, and EURETINA.

Dr. Monés’ research interests include macular diseases, choroidal neovascularization, macular degeneration, anti-angiogenic therapy, anti-PDGF therapy, geographic atrophy, retinal degeneration, retinal transplant, stem cells, gene therapy, macular edema, and vitreoretinal and macular surgery.

Dr. Monés is a member of the board of directors of FC Barcelona and, since 2010, has been responsible for the Medical and Sports Science Department. He is also the Commissioner of the FC Barcelona Universitas project.

Dr. Rafael Navarro

Retinal Specialist, Institute of Ocular Microsurgery, Spain

Dr. Rafael Navarro works in the Retina and Vitreous Department of the Institute of Ocular Microsurgery in Barcelona, Spain, where he is also a lecturer for the vitreous and retina master’s degree. Dr. Navarro is a graduate of the Autonomous University of Barcelona, and completed his ophthalmology residency at the Vall d’Hebron University Hospital in Barcelona in 1995. He subsequently worked as a retina specialist at two of the main public hospitals in Barcelona, the Hospital de Sant Pau and the Hospital Clinic of Barcelona, and joined the Institute of Ocular Microsurgery in 2000.

Dr. Navarro is actively involved in various international multicenter clinical trials focusing on AMD and DME. He has written numerous publications and is a member of the AAO, EURETINA, the Spanish Society of Ophthalmology, the Spanish Vitreo-Retinal Society, and the Club Jules Gonin.

In clinical practice, Dr. Navarro focuses on medical retina, particularly macular diseases, retinal vasculopathies, and hereditary retinal dystrophies.

Prof. Quan Dong Nguyen

Professor and Chair of the Department of Ophthalmology and Director of the Stanley M. Truhlsen Eye Institute, University of Nebraska Medical Center, USA

Professor Quan Dong Nguyen currently holds the McGaw Endowed Chair in Ophthalmology and is Professor and Chair of the Department of Ophthalmology and inaugural Director of the Stanley M. Truhlsen Eye Institute at the University of Nebraska Medical Center. Professor Nguyen was previously on the faculty at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, in Baltimore, Maryland, USA.

Professor Nguyen received his baccalaureate degree from the Phillips Exeter Academy, his bachelor’s and master’s degrees from Yale University, and his medical degree from the University of Pennsylvania. He completed an internship in internal medicine at the Massachusetts General Hospital and a residency in ophthalmology at Massachusetts Eye and Ear, Harvard Medical School. Professor Nguyen also completed fellowships in immunology and uveitis at Massachusetts Eye and Ear; ocular immunology at the Wilmer Eye Institute; and medical and surgical diseases of the vitreous and retina at the Schepens Eye Research Institute and Massachusetts Eye and Ear.

Professor Nguyen is a fellow of the AAO. He has received many commendations and awards, including the National Research Service Award and R01 Award from the National Institutes of Health, the Senior Achievement Award from the AAO, the Senior Honor Award from the American Society of Retina Specialists, and the Carl Camras Translational Research Award from ARVO.

Professor Nguyen serves as principal and co-investigator on multiple clinical trials sponsored by the National Eye Institute and other organizations for macular edema (from diabetes and uveitis), neovascular AMD, and ocular inflammatory and uveitic diseases. He is known for his innovative work in early, proof-of-concept, first-in-human clinical trials to evaluate potential pharmacotherapeutic agents for retinal vascular and uveitic diseases.

Professor Nguyen has chaired the US multicenter READ-2, READ-3 and iDEAL studies, evaluating the potential role of VEGF antagonists for DME. Recently, he led his team in the design and launch of the VIDI study, assessing the role of a vascular adhesion protein-1 inhibitor for DME. Professor Nguyen is also leading the SAVE and STOP-UVEITIS studies to evaluate the role of new pharmacologic agents, including specific interleukin inhibition, in uveitis and ocular inflammatory diseases.

Most recently, Professor Nguyen has been named the inaugural Editor-in-Chief of the American Journal of Ophthalmology Case Reports. He also serves on the editorial boards of various other scientific journals.

Prof. Masahito Ohji

Chair of the Department of Ophthalmology, Shiga University of Medical Science, Japan

Professor Masahito Ohji is Chair of the Department of Ophthalmology at the Shiga University of Medical Science in Otsu, Japan. He graduated from Osaka University Medical School in 1983, and completed a research fellowship at the University of Pittsburgh in Pennsylvania, USA. He returned to Japan after being appointed as Assistant Professor in the Department of Ophthalmology at Osaka University Medical School.

Professor Ohji is on the editorial board of several journals, including the Japanese journal of the Japanese Ophthalmological Society, Ophthalmology, Retina Today, the Journal of Japan Society for Laser Surgery and Medicine, and EyeNet, and is Co-editor of Graefe’s Archive for Clinical and Experimental Ophthalmology. He is also a committee member of both the Japanese Retina and Vitreous Society and the Japanese Society for Ocular Circulation, and is an advocate of the International Council of Ophthalmology and scientific advisor for AMD Alliance International.

Professor Ohji has contributed to more than 150 scientific publications, and has co-authored many chapters in ophthalmology textbooks. His research interests include retinal and vitreous biology.

Prof. Annabelle A. Okada

Professor of Ophthalmology and Director of the Ocular Inflammation Service and the Macular Disease Service (Kyorin University School of Medicine), Japan

Annabelle A. Okada is Professor of Ophthalmology at the Kyorin University School of Medicine in Tokyo, Japan, where she serves as Director of both the Ocular Inflammation Service and the Macular Disease Service. After graduating from Harvard Medical School in Boston, Massachusetts, USA, she completed an ophthalmology residency at Massachusetts Eye and Ear, Harvard Medical School; a uveitis fellowship at Tokyo Medical University (where she also obtained a doctorate in medical science); and a vitreoretinal fellowship at Osaka University.

Professor Okada is a member of numerous national and international ophthalmology societies and serves on the editorial boards of Ocular Immunology and Inflammation and the Japanese Journal of Ophthalmology, as well as the Japanese-language journal Atarashii Ganka. She has published more than 150 peer-reviewed articles and more than 40 textbook chapters, and is co-author on 4 textbooks.

Professor Okada’s research interests center on pharmaceutical treatments of ocular inflammation and exudative macular diseases. She is involved in several multicenter clinical trials and global research initiatives, and contributes to basic science research into the pathogenesis and development of new treatments for uveitis.

Prof. Calvin Pang

S. H. Ho Professor of Visual Sciences, Professor of Ophthalmology and Visual Sciences, and Chair of the Department of Ophthalmology and Visual Sciences, Chinese University of Hong Kong and Affiliated Institutes, China

Calvin Pang is S. H. Ho Professor of Visual Sciences, Professor of Ophthalmology and Visual Sciences, and Director of The Chinese University of Hong Kong (CUHK) Ophthalmic Research Centre, at the Department of Ophthalmology and Visual Sciences, CUHK. He is also Director of the Shantou University / CUHK Joint Shantou International Eye Center. Professor Pang received a BSc in biochemistry in 1978 from the University of London. He then completed a DPhil research program at the University of Oxford on an E. P. Abraham Research Fund Scholarship, followed by 2 years of postdoctoral research in Oxford.

Professor Pang has published 348 papers in international indexed peer-reviewed journals and 13 book chapters. He is a reviewer for the Wellcome Trust (UK), National Eye Institute (USA), National Medical Research Council (Singapore), Health Research Board (Ireland), Catalan Agency for Health Technology Assessment and Research (Spain), and National Natural Science Foundation (China). He is an advisor, and Honorary or Visiting Professor, of more than 25 clinical or research institutions and has numerous academic duties in mainland China.

Professor Pang’s research interests include (1) genomic studies and gene mapping of glaucoma, retinal diseases, myopia, and other complex eye diseases; (2) molecular genetics and epigenetics of retinoblastoma, thyroid-associated orbitopathy, diabetic retinopathy, retinitis pigmentosa, uveitis, corneal dystrophies, and hereditary optic neuropathies; (3) biology of ocular stem cells and; (4) biological effects of herbal molecules in eye disease.

Prof. Daniel Pauleikhoff

Chair of the Department of Ophthalmology (St. Franziskus-Hospital Münster) and Professor of Ophthalmology (University of Duisburg-Essen), Germany

Professor Daniel Pauleikhoff is currently Chair at the Department of Ophthalmology, St. Franziskus Hospital Münster, Germany; Professor of Ophthalmology at the Faculty of Medicine, Essen, Germany; and Honorary Professor at Moorfields Eye Hospital / UCL, London, UK. He was awarded his medical degree from the University of Münster, Germany, in 1983, and became research associate at the Department of Ophthalmology, University of Essen, Germany. Professor Pauleikhoff passed his residency in ophthalmology at the University of Essen, Germany, and a two-year fellowship at Moorfields Eye Hospital / UCL Institute of Ophthalmology in London with Professor Alan Bird. His main research activities focus on pathogenesis, phenotyping and therapy of AMD.

Professor Pauleikhoff is principal investigator for various interventional clinical trials in AMD, diabetic retinopathy and RVO, and has received many scientific grants for basic science and clinical investigations. He has organized several international symposia on AMD and is serving on the editorial boards of several scientific ophthalmological journals. He is an elected board member of the German Ophthalmological Society. He is also currently (2012–2016) President of the German Retina Society, serving on the board of this society as a Vice President for the previous 4 years. Professor Pauleikhoff has authored more than 150 publications in peer-reviewed journals, and he is Editor/Co-editor on several books on macular diseases and delivered several honorary lectures.

Mr. Ian Pearce

Consultant Ophthalmologist and Vitreoretinal Surgeon, Royal Liverpool University Hospital, UK

Mr. Ian Pearce is a consultant ophthalmologist and vitreoretinal surgeon at St. Paul’s Eye Unit, Royal Liverpool University Hospital, UK, providing specialist services for AMD, vitreoretinal surgery, diabetic eye disease, and uveitis.

Since 1993, Mr. Pearce has been involved in clinical research and has been principal/chief investigator for numerous international and national trials of novel treatments and therapies and surgical management of AMD involving radiotherapy.

Mr. Pearce is past President of the Ophthalmic Imaging Association, Director of the Clinical Eye Research Centre at St. Paul’s Eye Unit, and member of the Royal College of Ophthalmologists Scientific Committee. He is the nominated Specialist Clinical Expert Advisor to the National Institute for Health and Care Excellence for the appraisal of novel technologies for the treatment of retinal diseases. For the Department of Health, he is Chair of the Advisory Committee on Dangerous Pathogens TSE Ophthalmic Subgroup.

As well as delivering numerous invited international and national lectures, Mr. Pearce has authored 3 national guidelines, 3 book chapters (Evidenced-based Management of Diabetes, Complications of Vitreo-retinal Surgery, and a chapter in Barton and Powers’ Clinical Negligence) and more than 50 publications, which have been cited >700 times.

Mr. Pearce has trained many UK and international retinal specialists through St. Paul’s Eye Unit fellowship programs, and is Regional Advisor for Ophthalmology to Mersey Training Deanery, Mersey Deanery Programme Director for Medical Ophthalmology, and examiner for the Royal College of Ophthalmologists.

Prof. Christian Prünte

Professor of Ophthalmology and Head of the Department of Ophthalmology, University of Basel, Switzerland

Christian Prünte is Professor of Ophthalmology and Head of the Department of Ophthalmology at Kantonsspital Baselland, Liestal, Switzerland. He has held the position of Professor of Ophthalmology since June 2004. Professor Prünte received his medical degree in 1984 at the RWTH Aachen University, Germany, and undertook his residency in ophthalmology at the University Eye Clinic Basel. Since his residence, he has held the positions of Chief Resident, Head of Day-Care Surgery, Head of the Department of Ophthalmic Diagnostics, and Vice Chair and Head of Clinical Ophthalmic Surgery at the University Eye Clinics in Bern, Munich, and Basel.

Professor Prünte is a member of several medical societies, including the Swiss Society of Ophthalmology, the German Ophthalmological Society, the German Retina Society, EURETINA, and ARVO. He is currently Chair of the Swiss Vitreo-Retinal Society.

Dr. Francisco J. Rodríguez

Scientific Director (Fundación Oftalmológica Nacional) and Chair of the Department of Ophthalmology (Universidad del Rosario School of Medicine), Colombia

Dr. Francisco J. Rodríguez is the Scientific Director of the Fundación Oftalmológica Nacional and Chair of the Department of Ophthalmology at the Universidad del Rosario School of Medicine in Bogotá, Colombia. He received his medical degree from the Universidad del Rosario School of Medicine in 1986, and carried out his ophthalmology residency at the Fundación Oftalmológica Nacional. Dr. Rodríguez then completed a vitreoretinal surgical fellowship at the Jules Stein Eye Institute, UCLA, Los Angeles, California, USA, and a medical retina fellowship at the Manhattan Eye, Ear and Throat Hospital, New York. This was followed by an electrophysiology / hereditary retinal diseases fellowship at the Bascom Palmer Eye Institute, University of Miami Leonard M. Miller School of Medicine in Florida.

Dr. Rodríguez has participated as principal investigator in several clinical trials, and has received several awards, including the National Academy of Medicine Award in 1997. He has more than 65 publications in national and international peer-reviewed journals and has authored several chapters in retina books.

Dr. Rodríguez’s research interests include diabetic retinopathy, AMD, retinal vein occlusion, inflammatory diseases of the retina and choroid, hereditary diseases of the retina, retinal detachment, retinal imaging and management of ocular trauma.

Dr. Paisan Ruamviboonsuk

President of the Royal College of Ophthalmologists of Thailand and Assistant Director of the Centre of Medical Excellence (Rajavithi Hospital), Thailand

Dr. Paisan Ruamviboonsuk received his medical degree from Mahidol University, Thailand, in 1987. He is currently Chair of the Department of Medical Policy Development and Strategic Planning, and Assistant Hospital Director, Center of Medical Excellence, Rajavithi Hospital, Bangkok, Thailand. He is also a retinal specialist serving in the Center of Excellence for Vitreous and Retina Diseases at the same hospital.

Since 2012, Dr. Ruamviboonsuk has been President of the Royal College of Ophthalmologists of Thailand. He is also a member of the American Society of Retina Specialists, a council member of the Asia-Pacific Vitreo-retina Society, and Secretary General of the ASEAN Ophthalmology Society. He was President of the Thai Retina Society from 2009 to 2014.

Dr. Ruamviboonsuk received the United Nations Public Service Award for his project on prevention of blindness from diabetic retinopathy in 2012. He also received the APAO Distinguished Service Award and APAO Achievement Award in 2007 and 2014.

Dr. Ruamviboonsuk is one of the pioneers in the field of polypoidal choroidal vasculopathy in the Asia-Pacific region. His published work also includes studies on diabetic retinopathy imaging and economic impact of AMD. He has been an invited speaker at many international ophthalmologic meetings and a reviewer for numerous international peer-reviewed journals.

Dr. Taiji Sakamoto

Kagoshima University Graduate School of Medical and Dental Sciences, Japan

Professor Taiji Sakamoto, MD, PhD graduated from Kyushu University, Japan and worked as a visiting research instructor at Doheny Eye Institute, USC, in California, USA until 1995. He studied gene therapy and molecular pathology and returned to Japan and became the professor and chair of Kagoshima University in Japan from 2002.

He is an executive committee member of the Japanese Ophthalmological Society, the Japanese Vitreous Retina Society, Japan Ocular Circulation Society, and others. He is also a member of Club Jules Gonin and a faculty member of ARVO. He serves the Japanese government as a collaborative member of the science council.

He has received many awards from scientific societies, including the RPB foreign scholarship award, the Pfizer Ophthalmic Award, the Rohto Award, the Japanese Ophthalmological Society Committee Award, the Gold ARVO Fellow award, and others.

His research and clinical interests are in diabetic retinopathy, vitrectomy, ocular angiogenesis, drug delivery, and gene therapy. He has published more than 300 peer-reviewed papers.

Prof. Reinier O. Schlingemann

Professor of Ocular Angiogenesis in the Faculty of Medicine (University of Amsterdam) and Head of the Ocular Angiogenesis Group (University of Amsterdam Academic Medical Centre), The Netherlands

Dr. Reinier O. Schlingemann is among the foremost researchers in ocular angiogenesis and anti-VEGF therapy in the eye. After receiving his medical degree from the University of Leiden Medical School, the Netherlands, Dr. Schlingemann gained his PhD from the University of Nijmegen in 1990, on the subjects of tumor angiogenesis and tumor vascular targeting. He undertook his residency in ophthalmology at the University of Amsterdam, followed by a medical retina fellowship with Professor Alan Bird at Moorfields Eye Hospital, London. He is now Professor of Ophthalmology and a medical retinal specialist in Amsterdam.

Dr. Schlingemann’s research interests include the role of growth factors in ocular angiogenesis and fibrosis (particularly in AMD and diabetic retinopathy); the cellular mechanisms underlying loss of the blood–retinal barrier in diabetic retinopathy; and vaso-occlusive mechanisms that cause non-perfusion of the retinal vasculature in diabetic retinopathy. He is also involved in several prospective clinical trials on the use of anti-angiogenic therapy in AMD and diabetic retinopathy.

Prof. Figen Şermet

Chair of the Ophthalmology Department, Ankara University School of Medicine, Turkey

Professor Figen Şermet is Chair of the Ophthalmology Department at Ankara University, Turkey. She completed her medical degree at the Hacettepe University Faculty of Medicine and her residency at the Ankara University Faculty of Medicine. She worked as a specialist doctor in ophthalmology before being appointed as Assistant Professor at Ankara University in 1996. Since then, she has been promoted to Associate and then Full Professor in Ophthalmology.

Professor Şermet is an active member of the Turkish Ophthalmology Society in both the medical retina and vitreoretinal surgery divisions. She is also a member of the American Society of Retina Specialists and EURETINA. She is in the ESASO faculty and gives lectures on medical and surgical retina modules.

Professor Şermet has been a co-investigator in numerous clinical trials and has published more than 70 papers in international peer-reviewed journals. Her research interests include medical and surgical vitreoretinal diseases, retinopathy of prematurity, imaging, and uveitis.

Prof. Sobha Sivaprasad

Professor of Retinal Clinical Studies (UCL Institute of Ophthalmology) and Consultant Ophthalmologist (Moorfields Eye Hospital), UK

Sobha Sivaprasad is Professor of Retinal Clinical Studies at the UCL Institute of Ophthalmology in London, UK. She is also a consultant ophthalmologist at Moorfields Eye Hospital, London, specializing in medical retina. Her higher research degree was on AMD, and she obtained her medical retina fellowship from Moorfields Eye Hospital.

Professor Sivaprasad has active clinical and laboratory research interests in AMD, diabetic retinopathy, and retinal vascular disorders. Her research focuses on biomarkers and modeling of retinal morphology in retinal diseases. She oversees several multicenter clinical trials in these areas and has contributed to more than 100 peer-reviewed publications. She is an Editor of Eye and is a peer-reviewer of several international ophthalmic journals.

Prof. Giovanni Staurenghi

Professor of Ophthalmology, Chair (University Eye Clinic), and Director of the University Eye Clinic Department of Biomedical and Clinical Sciences “Luigi Sacco” (Luigi Sacco Hospital), Italy

Giovanni Staurenghi is currently Professor of Ophthalmology, Chair of the University Eye Clinic, Director of the University Eye Clinic Department of Biomedical and Clinical Sciences “Luigi Sacco” at Luigi Sacco Hospital in Milan, Italy, and Director of the Residency Program at the same university. He was awarded his degree at the University of Pavia, Italy, in 1986, and completed his residency at the University of Milan in 1990. He was a research fellow at the Schepens Eye Research Institute in Boston, Massachusetts, USA, from 1991 to 1992 and visiting scientist at the same institute from 1992 to 1993. He became Associate Professor in 1999 and was promoted to Full Professor in 2007.

Professor Staurenghi is a scientific advisor of the Digital Angiography Reading Center and Visiting Professor and consultant for the Belfast Ophthalmic Reading Center at the Central Angiographic Resource Facility. He is also a member of the editorial board of Investigative Ophthalmology and Visual Science and acts as a reviewer for many international scientific journals. He is an ARVO Silver Fellow.

Professor Staurenghi’s research, publications and lectures have an important bearing on retinal degeneration; in particular, his work is focused on different types of imaging and treatment. He has been a member of ARVO since 1988, the Macula Society since 2004, the Ophthalmic Photographers’ Society since 2006, and the AAO since 2007. He was part of the Annual Meeting Program Committee for ARVO from 2008 to 2010.

Mr. James Talks

Consultant Ophthalmologist, Royal Victoria Infirmary, UK

Mr. James Talks is a consultant ophthalmologist and honorary senior lecturer at the Royal Victoria Infirmary in Newcastle upon Tyne, UK. He moved to his current position after completing a medical retina fellowship at Moorfields Eye Hospital in London.

Mr. Talks is on the council and Scientific Committee of the Royal College of Ophthalmologists and on the council of the Oxford Ophthalmological Congress.

Mr. Talks has a focus on medical retina. His research interests include AMD, diabetic retinopathy, retinal vascular conditions, cataract surgery, and retinal imaging. He has recently published papers on real-world treatment outcome data and wide-field imaging in diabetics, and is leading a multicenter national data collection audit of anti-VEGF treatment outcomes in the UK. For the last 8 years, he has jointly run an imaging course at the Royal College of Ophthalmologists Annual Congress.

Prof. Hiroko Terasaki

Professor of Ophthalmology, Nagoya University Graduate School of Medicine, Japan

Dr. Terasaki has been Professor of Ophthalmology at the Nagoya University Graduate School of Medicine for 18 years. Nagoya University is one of the top universities in Japan and has a 130-year history, during which Dr. Terasaki became the first female professor and Chair.

She has performed thousands of surgeries, including difficult surgeries such as retinopathy of prematurity. She has been persistent in continuing to conduct basic and translational research for those with unmet needs, even after taking on the position of Chair at the Nagoya University Graduate School of Medicine for 12 years.

Dr. Terasaki has published more than 280 peer-reviewed English articles and has been involved in more than 30 clinical trials, some as principal investigator. She served as Associate Chief Editor of the Japanese Journal of Ophthalmology for 6 years and is currently an editorial board member of IOVS and Graefe's Archive for Clinical and Experimental Ophthalmology.

She has been an active member of the Club Jules Gonin since 2004, a member of the Association for Research in Vision and Ophthalmology since 1996, an international member of AAO since 1998, and an international member of Clinical Electrophysiology of Vision. She was recently appointed APAO fellow in the Asia-Pacific region.

Dr. Terasaki was awarded the Japanese Ophthalmological Society (JOS) Award and the Mori Award, which is the most prestigious award of the Japanese Retina and Vitreous Society, for contributions to the field of ophthalmology, as well as the vitreo-retina.

In addition to her energetic research and clinical work, Dr. Terasaki has served as the Executive Board Director at JOS for 7 years. She was also an important member of the Ministry of Health, Labour and Welfare and the Japan Medical Association, and was an advisor to the Japanese Ministry of Science and Technology, through which she contributed to advancing science.

Dr. Miltiadis Tsilimbaris

Professor and Chief at the University Eye Clinic and Director of the Laboratory of Optics and Vision, University of Crete Medical School, Greece

Dr. Miltiadis Tsilimbaris is Professor and Chief of the University Eye Clinic of Heraklion in Crete, Greece. He received his medical degree from the University of Crete Medical School and completed his residency in the University Eye Clinic of Heraklion. He is Director of the Laboratory of Optics and Vision at the University of Crete Medical School.

Dr. Tsilimbaris’s clinical work is mainly focused on vitreoretinal diseases and he is an active vitreoretinal surgeon. He retains a strong research interest in retinal diseases, with research projects including, among others, the development of sustained-release formulations of NSAIDs for intravitreal use; evaluation of new anti-apoptotic compounds in models of retinal apoptosis; exploration of alternative uses of photodynamic therapy; the study of the role of lipids in AMD; and development of imaging techniques for the evaluation of the perifoveal capillary network.

Dr. Tsilimbaris shares his professional time between clinical care, research, and teaching. He is a member of the Greek Vitreoretinal Society, ARVO, AAO, Club Jules Gonin, and EURETINA, in addition to having published over 160 papers in peer-reviewed journals and holding three patents.

Dr. Francesco Viola

Assistant Professor of Ophthalmology (University of Milan) and Director of Vitreoretinal Service (Fondazione Cà Granda, Ospedale Maggiore Policlinic), Italy

Dr. Francesco Viola is currently Assistant Professor of Ophthalmology at the University of Milan and director of Vitreoretinal Service at the Fondazione Cà Granda, Ospedale Maggiore Policlinico of Milan, Italy. He completed his residency in ophthalmology at the University of Brescia and completed a research fellowship in retina at Massachusetts Eye and Ear, Harvard Medical School, in Boston, Massachusetts, USA.

Dr. Viola is currently principal investigator of more than 20 major clinical trials for the treatment of macular diseases, and has published more than 50 articles in peer-reviewed journals. He serves as a reviewer on numerous peer-reviewed journals, including Investigative Ophthalmology and Visual Science, Ophthalmology, American Journal of Ophthalmology, and Retina. He is also a frequent speaker at national and international meetings and a member of many professional organizations.

Dr. Viola’s main research activities focus on pathogenesis and therapy of medical and surgical retina, as well as on retinal imaging methodologies and phenotyping. His major clinical interests are in medical and surgical retina.

Prof. Wenbin Wei

Professor and Director of the Department of Ophthalmology, Beijing Tongren Hospital, China

Wenbin Wei is a professor at, and the director of, the Department of Ophthalmology at Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Prof. Sebastian Wolf

Professor of Ophthalmology, Director, and Chair of the Department of Ophthalmology, Inselspital, Switzerland

Sebastian Wolf is Professor of Ophthalmology, Director and Chair of the Department of Ophthalmology, Inselspital, University of Bern, Switzerland. He earned a PhD degree for biotechnical engineering from the RWTH Aachen University, Germany, and subsequently attended medical school at the same university. He completed his residency in ophthalmology at the RWTH Aachen University and undertook various fellowships at the Schepens Eye Research Institute and Harvard Medical School in Boston, Massachusetts, USA, and the Department of Ophthalmology at the RWTH Aachen University.

Professor Wolf has authored more than 180 publications in peer-reviewed journals, including Ophthalmology, Archives of Ophthalmology, American Journal of Ophthalmology, Investigative Ophthalmology and Visual Science, Diabetes Care, and Hypertension. He serves on the editorial board of various scientific journals, including Investigative Ophthalmology and Visual Science, Ophthalmologica, European Journal of Ophthalmology, and Graefe’s Archive for Clinical and Experimental Ophthalmology. He is a frequent speaker at national and international meetings.

Professor Wolf is a member of many professional organizations, including ARVO, the Retina Society, EURETINA, the Club Jules Gonin, and the AAO. He has been appointed as ARVO Gold Fellow, and has served for 5 years as General Secretary of EURETINA and been elected as President Elect of EURETINA.

Professor Wolf’s major clinical interests are in medical and surgical retina. His main areas of scientific interest are AMD, diabetic retinopathy, RVO, imaging, and vitreoretinal surgery.

Dr. David Wong

Associate Professor (University of Toronto) and Ophthalmologist-in-Chief (St. Michael’s Hospital), Canada

Dr. David Wong is currently an Associate Professor at the University of Toronto in Ontario, Canada, specializing in retina and vitreous surgery. He is on staff at St. Michael’s Hospital, Oakville-Trafalgar Memorial Hospital and Trillium Health Centre in Ontario, and is Ophthalmologist-in-Chief at St. Michael’s Hospital. He is a previous honors graduate from the University of Toronto’s medical doctorate program and completed his residency in ophthalmology at the University of Toronto, followed by fellowships in Toronto and at Columbia University in New York, USA.

Dr. Wong is a member of the Canadian Ophthalmological Society, AAO, the American Society of Retina Specialists, and ARVO. He is also on the board of directors for the 20/20: NSERC Ophthalmic Materials Network, and consultant to several companies in industry.

Dr. Wong has been awarded numerous local and international awards, including the Senior Honor Award from the American Society of Retina Specialists. He is the past Director of the fellowship programs in the Department of Ophthalmology and Vision Sciences at the University of Toronto, and founded the national fellowship committee in the Canadian Ophthalmological Society. Dr. Wong has been a frequent invited speaker in North and South America, Asia and Europe, and has authored numerous scientific papers and book chapters in various areas of vitreoretinal diseases, including trauma, complex surgeries, new surgical techniques, AMD, RVO, and diabetes.

Dr. Wong’s recent research interests include improving diabetic retinopathy surveillance to allow diagnosis during early stage disease, and he is also interested in developing new ophthalmic biomaterials.

Prof. Tien Yin Wong

Medical Director (Singapore National Eye Centre), Provost’s Chair Professor of Ophthalmology (Duke-NUS Graduate Medical School), and Chair of the Singapore Eye Research Institute, Singapore

Professor Tien Yin Wong is Medical Director of the Singapore National Eye Centre, and Provost’s Chair Professor of Ophthalmology at the Duke-NUS Graduate Medical School, National University of Singapore, and Chair of the Singapore Eye Research Institute.

Professor Wong is a retinal specialist and scientist; he balances clinical management of retinal and macular diseases, such as diabetic retinopathy and AMD, with research into the use of novel retinal imaging techniques to predict diabetic and cardiovascular diseases. He has contributed to more than 1000 publications, including papers in the New England Journal of Medicine and The Lancet, and has given more than 300 invited named, plenary, and symposium lectures around the world.

Professor Wong has been recognized internationally and nationally for his work, and has received numerous awards, including the Singapore Translational Research Investigator Award, the National Outstanding Clinician Scientist Award, the President’s Science Award, the Alcon Research Institute Award, the Commonwealth Health Minister’s Award for Excellence in Health and Medical Research, and the Arnall Patz Medal from the Macula Society.

Dr. Lihteh Wu

Associate Professor (University of Costa Rica) and Director of the Vitreo-Retinal Department (Instituto de Cirugía Ocular), Costa Rica

Following the completion of his undergraduate studies at Cornell University, from which he graduated with distinction in all subjects, Dr. Lihteh Wu went on to Tulane University School of Medicine to pursue his medical education. During this time, he was awarded a Pew Research Fellowship that allowed him to spend a year at the Rockefeller University in New York. He then trained at Columbia Presbyterian Hospital in New York City (internship), the Mount Sinai Medical Center in New York City (ophthalmology residency), and the National Retina Institute in Baltimore under the mentorship of Drs. Bert Glaser and Robert Murphy (vitreoretinal fellowship). In 1999, Dr. Wu returned to Costa Rica, where he was appointed Associate Professor at the University of Costa Rica and Director of the Asociados de Macula Vitreo y Retina de Costa Rica in San José, Costa Rica.

Dr. Wu is a founding member of the Pan-American Collaborative Retina Study (PACORES) Group. He has authored and co-authored more than 50 peer-reviewed articles and over 40 chapters, and has edited 5 books. He has been awarded the Senior Honor Award (2007) by the American Society of Retina Specialists; the Senior Honor Award (2010) by the Greek Vitreoretinal Society; and the Achievement Award (2006) and Senior Achievement Award (2013) by the AAO. In addition, he was the 2014 Sociedad Panamericana de Retina y Vitreo GLADAOF Lecturer.

Dr. Wu is past President of the Pan-American Retina and Vitreous Society and also served two terms as President of the Costa Rican Ophthalmological Association. He is the current Vice President for the PAAO, and is currently serving on the board of trustees of the AAO. In addition, he is certified by the American Board of Ophthalmology. He is a member of the Club Jules Gonin, Macula Society, Retina Society, and American Society of Retina Specialists. Dr. Wu has been invited to speak at several international meetings, such as the AAO Retina Subspecialty Day and the Vail Vitrectomy Meeting.

Prof. Yasuo Yanagi

Associate Professor, Singapore National Eye Centre, Japan

Professor Yasuo Yanagi specializes in retinal disorders and served as Director of both the Macula Clinic and the Retina Clinic of the University of Tokyo Hospital, affiliated with the University of Tokyo, Japan. He continued his basic and clinical research at the University of Tokyo, and is currently working at the Singapore National Eye Centre / Singapore Eye Research Institute. He is affiliated with the Duke-NUS Graduate Medical School in Singapore.

Professor Yanagi’s basic research accomplishments include the discovery of novel molecular targets and the development of a novel drug delivery system targeting neovascular AMD. In addition, he is also leading several important clinical research projects through which his group has contributed significantly to the understanding of Asian AMD.

Professor Yanagi is the author of approximately 100 peer-reviewed international papers. His work has been published in top biomedical journals such as Science, Nature Materials, and the Journal of Biological Chemistry, as well as in specialized journals in ophthalmology and visual sciences, such as Ophthalmology, Archives of Ophthalmology, the American Journal of Ophthalmology, and Investigative Ophthalmology and Visual Science.

Prof. Young Hee Yoon

Professor of Ophthalmology, Asan Medical Center, South Korea

Young Hee Yoon is Professor of Ophthalmology at the Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. She graduated from Seoul National University Medical School, and was trained as a vitreoretinal fellow at the Doheny Eye Institute in Los Angeles, California, USA.

Professor Yoon’s main research interests are retinal cell death and ocular angiogenesis. She has authored or co-authored more than 100 articles in various international peer-reviewed journals and has been awarded numerous honors, including an Academic Achievement Award from the Korean Retina Society and the Arthur Lim Award from the Asia-Pacific Academy of Ophthalmology. In 2015, she was inducted into the Doheny Society of Scholars at the Doheny Eye Institute.

Professor Yoon is an active vitreoretinal surgeon, conducting over 10,000 vitreoretinal surgeries, and has been involved in 25 Phase II and III global clinical trials. She is a member of several prominent international societies, including ARVO, AAO, the American Society of Retina Specialists, the Retina Society, and the Club Jules Gonin.

Dr. Miguel A. Zapata

Clinical Associate Professor (Autonomous University of Barcelona) and Specialist in Retina and Ophthalmology (Vall d’Hebron University Hospital), Spain

Dr. Miguel A. Zapata is a Clinical Associate Professor at the Autonomous University of Barcelona and a specialist in retina and ophthalmology at Vall d’Hebron University Hospital, Spain. His expertise is in the field of medical and surgical retina, with particular emphasis on macular degeneration and diabetic retinopathy.

Dr. Zapata has presented papers at numerous national and international conferences and currently has 22 indexed publications. He received an award for the best paper at the Spanish Retina and Vitreous Society Congress in 2014.

Dr. Zapata’s main research interests are clinical and basic macular degeneration, diabetic retinopathy, and development of new drugs for the treatment of retinal diseases. In clinical research, he has been the principal investigator of five projects in the last 4 years and collaborator in more than 20 clinical trials and translational research projects.